Literature DB >> 11459462

In vitro gene transfer with a novel galactosylated spermine bolaamphiphile.

J Gaucheron1, C Santaella, P Vierling.   

Abstract

We describe the synthesis of a alpha-galacto-omega-spermine bolaamphiphile (GalSper) and report on the gene transfer mediated with lipoplexes it forms either when used alone or in conjunction with DOPE or with DOGS (Transfectam). Lipofection with GalSper was investigated with human HepG2 or murine BNL-CL2 hepatocytes expressing the asialo-glycoprotein (ASGP) receptor, which displays a high affinity for galactosyl residues, or with A549 cells which do not express ASGP. Although lower luciferase expression levels in BNL-CL2 and in HepG2 cells were obtained with GalSper/DOPE N/P 2.5 lipoplexes as compared with control DOGS/DOPE N/P 2.5 particles or with the more positively charged N/P 5 particles (yet through a different mechanism), specific receptor-mediated endocytosis of DNA can be achieved with this targeted cationic GalSper bolaamphiphile presenting a single galactose residue. The present work suggests that GalSper-based DNA formulations appear as promising synthetic vectors for specific gene delivery to ASGP(+) cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459462     DOI: 10.1021/bc000165x

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

Review 1.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

Review 2.  Amphiphilic peptides as novel nanomaterials: design, self-assembly and application.

Authors:  Feng Qiu; Yongzhu Chen; Chengkang Tang; Xiaojun Zhao
Journal:  Int J Nanomedicine       Date:  2018-09-03

Review 3.  Biomedically Relevant Applications of Bolaamphiphiles and Bolaamphiphile-Containing Materials.

Authors:  Jake R Hughes; Alyssa S Miller; Camryn E Wallace; Gopi Nath Vemuri; Peter M Iovine
Journal:  Front Chem       Date:  2021-01-20       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.